Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.71% | 10.69% | 6.53% | 14.43% | 20.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.71% | 10.69% | 6.53% | 14.43% | 20.79% |
| Cost of Revenue | -1.25% | -0.72% | -0.22% | 0.16% | -1.89% |
| Gross Profit | 17.64% | 12.80% | 7.78% | 17.40% | 26.15% |
| SG&A Expenses | 21.14% | 23.96% | 27.41% | 34.39% | 39.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 34.74% | 21.26% | 6.09% | 0.58% | -1.84% |
| Total Operating Expenses | 16.18% | 16.66% | 17.25% | 21.33% | 22.91% |
| Operating Income | -28.99% | -88.43% | -235.99% | -119.20% | -44.95% |
| Income Before Tax | 13.66% | -100.14% | -2,913.02% | -774.10% | -338.69% |
| Income Tax Expenses | 769.75% | 899.49% | 1,279.78% | 31.27% | -70.65% |
| Earnings from Continuing Operations | 8.82% | -105.99% | -2,846.93% | -713.32% | -303.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.82% | -105.99% | -2,846.93% | -713.32% | -303.86% |
| EBIT | -28.99% | -88.43% | -235.99% | -119.20% | -44.95% |
| EBITDA | -47.70% | -203.43% | -9,198.96% | -375.64% | -81.57% |
| EPS Basic | 9.46% | -106.41% | -3,050.00% | -789.47% | -335.29% |
| Normalized Basic EPS | 14.13% | -97.96% | -2,800.00% | -845.45% | -384.21% |
| EPS Diluted | 9.46% | -101.25% | -1,790.00% | -634.78% | -289.47% |
| Normalized Diluted EPS | 14.13% | -97.96% | -2,800.00% | -845.45% | -384.21% |
| Average Basic Shares Outstanding | 0.35% | 0.31% | 0.26% | -1.24% | -2.71% |
| Average Diluted Shares Outstanding | 0.35% | -0.89% | -2.10% | -3.54% | -4.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
